Suzhou, China · Founded 2019 · Privately Held (backing)
Developer of mRNA based therapeutics focused on advancing clinical stage RNA medicines with a mission to revolutionise the future of health and life. AbogenBio is based in Suzhou, China and was founded in 2019. Its last reported valuation was $3.7 billion in Nov 2021. It has raised $1.1 billion.
Last reported valuation
$3.7B
Oct 2026
Priced at
—
Total raised
$1.1B
Last round
—
Team — not yet on record
No current team members for AbogenBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AbogenBio with a free account
·The complete investor list: 44 names
·Watch AbogenBio: the Monday email on marks, rounds and moves
